2018/08/20MEDICAL UPDATE

ASCO 2018: Synchronous primary lung cancers

Professor John Lafrate (Harvard Medical School, Boston) and Professor Frank Detterbeck (Yale School of Medicine, New Haven) spoke in a session looking at some of the difficulties with diagnosis and management of synchronous primary lung cancers, especially as there is little research or guidelines to guide best practice.

READ MORE

2018/08/20MEDICAL UPDATE

ASCO 2018: KEYNOTE-042 shows OS

by Thomas R Collins First-line treatment with the PD-1 inhibitor pembrolizumab showed an overall survival benefit compared to platinum-based chemotherapy in patients with locally advanced or metastatic non-small cell lung cancer and a PD-L1 tumour proportion score of at least 1…

READ MORE

2018/08/20MEDICAL UPDATE

ASCO 2018: Choices for front-line NSCLC

By Thomas R Collins With permutations of potential front-line treatments for non-small cell lung cancer (NSCLC) seemingly endless, one thing seems certain…

READ MORE

2018/08/20MEDICAL UPDATE

ASCO 2018: Hot topics in lung cancer

Hot topics in lung cancer - interviews from ASCO 2018.

READ MORE

2018/08/20MEDICAL UPDATE

ASCO Highlights

June 2018 saw the launch of our first edition of LungCancer.Med, a new congress news e-journal containing interviews with speakers and delegates as well as articles on the latest hot topics in lung cancer.

READ MORE